Bioxytran, Inc.
BIXT
$0.03
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -296.21% | -84.72% | -898.59% | 102.62% | -79.98% |
| Total Depreciation and Amortization | -27.59% | -30.95% | 68.00% | 31.58% | -34.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,264.41% | 237.80% | 72.18% | -125.82% | 400.44% |
| Change in Net Operating Assets | 144.16% | -41.92% | 111.86% | -6.50% | -53.93% |
| Cash from Operations | -0.68% | -471.08% | 48.57% | 51.76% | -30.81% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -48.39% | -264.71% | 88.82% | -- | 100.00% |
| Cash from Investing | -48.39% | -264.71% | 88.82% | -- | 100.00% |
| Total Debt Issued | -- | -49.51% | -56.45% | -43.18% | 50.68% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -65.77% | 3,076.12% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -67.39% | -- | -- | -- | -- |
| Cash from Financing | -72.79% | 1,255.23% | -42.39% | -43.18% | 50.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -109.47% | 4,245.61% | 1,050.00% | -50.00% | 97.29% |